Valuation: Ainos, Inc.

Market Cap 10.34M 8.93M 8.4M 7.64M 14.36M 990M 14.57M 98.54M 38.62M 495M 38.81M 37.97M 1.65B P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 20.92M 18.07M 17M 15.45M 29.06M 2B 29.49M 199M 78.15M 1B 78.55M 76.84M 3.34B EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
24.76%
Yield 2024 *
-
Yield 2025 -
1 day-1.41%
1 week-5.41%
Current month+5.26%
1 month-15.15%
3 months-15.65%
6 months+3.70%
Current year-14.63%
1 week 1.37
Extreme 1.37
1.56
1 month 1.3
Extreme 1.3
1.7
Current year 1.26
Extreme 1.26
3.88
1 year 1.26
Extreme 1.26
4.44
3 years 1.26
Extreme 1.26
21.6
5 years 1.26
Extreme 1.26
450
10 years 1.26
Extreme 1.26
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 2021-04-14
Director of Finance/CFO 54 2024-03-14
Director TitleAgeSince
Director/Board Member 72 2021-04-14
Director/Board Member 68 2022-06-14
Director/Board Member 49 2021-04-14
Date Insider Type Main position Quantity % Market Cap.
5/19/26 Buy

Director

2,200 0.0315%
4/29/26 Buy

Director

300 0.0041%
1/28/26
Taiwan Carbon Nano Technology Corp.
SellCompany 46,000 0.6588%
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%-5.41%-58.21%-91.64% 10.34M
+0.60%-2.64%+20.82%+10.64% 218B
-1.51%-3.79%-4.51%-20.62% 140B
+0.22%-2.50%-18.72%+36.80% 138B
-1.87%-1.41%-51.02%+0.56% 73.14B
+0.19%-2.86%+16.19%+18.80% 52.44B
-0.10%-0.33%-16.45%-13.29% 50.85B
-0.01%-0.70%+25.64%+24.48% 41.92B
-1.59%-3.31%+38.65%+48.61% 39.42B
+0.36%-0.16%-0.74%+6.25% 32.81B
Average -0.51%-2.16%-4.84%+2.06% 78.69B
Weighted average by Cap. -0.30%-2.30%+0.21%+10.18%

Financials

2024 2025
Net sales 20.73K 17.9K 16.85K 15.31K 28.8K 1.99M 29.22K 198K 77.44K 993K 77.83K 76.14K 3.31M 124K 107K 101K 91.7K 172K 11.9M 175K 1.18M 464K 5.95M 466K 456K 19.82M
Net income -14.86M -12.84M -12.08M -10.98M -20.65M -1.42B -20.95M -142M -55.52M -712M -55.8M -54.59M -2.37B -14.77M -12.76M -12M -10.91M -20.52M -1.42B -20.82M -141M -55.18M -708M -55.46M -54.25M -2.36B
Net Debt 8.11M 7M 6.59M 5.99M 11.26M 777M 11.43M 77.28M 30.29M 388M 30.44M 29.78M 1.29B 10.58M 9.14M 8.6M 7.82M 14.7M 1.01B 14.92M 101M 39.53M 507M 39.73M 38.87M 1.69B
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
26-08-18 $1.400 -1.41% 39,687
26-08-17 $1.420 0.00% 188,361
26-08-14 $1.420 -1.39% 21,186
26-08-13 $1.440 -3.36% 14,393
26-08-12 $1.490 +0.68% 42,625
  1. Stock Market
  2. Stocks
  3. AIMD Stock